This compound is an active pharmaceutical ingredient characterized by a highly polar, ring-containing structure with multiple hydrogen-bond donors and acceptors, including a halogen atom and an aromatic heterocycle.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
1-(Ethyl-1,1,2,2,2-d5)-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid
pharmaceutical raw material
Trenbolone acetate
pharmaceutical raw material
N-Desmethyl Clarithromycin
pharmaceutical raw material
Olanzapine Lactam Impurity
pharmaceutical raw material
[[(2R,3R,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate
IPHULAIUXUVCHH-VPCXQMTMSA-N
C[C@]1([C@@H]([C@H](O[C@H]1N2C=CC(=O)NC2=O)COP(=O)(O)OP(=O)(O)OP(=O)(O)O)O)F
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.